J. M. Nesland

University of Oslo — Norway

Medicine · Health Sciences

32h-index3.7kcitations64works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related Molecular Pathways(10), Cancer Genomics and Diagnostics(10), Breast Cancer Treatment Studies(6), Genetic factors in colorectal cancer(6), Cancer Cells and Metastasis(5)

Publications64 total

Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c
British Journal of Cancer·2014· 119 citedOpen Access
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer
British Journal of Cancer·2012· 23 citedOpen Access
Fine needle aspirations in oncology.
PubMed·2011· 10 cited
CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer
Genes and Immunity·2011· 50 citedOpen Access
Disseminated tumour cells as a prognostic biomarker in colorectal cancer
British Journal of Cancer·2011· 55 citedOpen Access
PINCH‐2 expression in cancers involving serosal effusions using quantitative PCR
Cytopathology·2010· 13 citedOpen Access
A Comparative Study of the Effects of Non-Union of Testis and Epididymis and Cryptorchidism on Testicular Development and Spermatogenesis in the Rat
Andrologia·2009· 2 cited
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome
The Journal of Pathology·2007· 383 cited
Protein networking in bladder cancer: immunoreactivity for FGFR3, EGFR, ERBB2, KAI1, PTEN, and RAS in normal and malignant urothelium.
PubMed·2007· 31 cited
Expression of matrix metalloproteinase-2 in serous borderline ovarian tumors is associated with noninvasive implant formation.
PubMed·2007· 4 cited
Asbestos fibers in ovarian tissue from Norwegian pulp and paper workers
International Journal of Gynecological Cancer·2006· 27 cited
Enhanced Expression of Metallinoproteases (Mmp-2) in Primary Serous Borderline Ovarian Tumors With Implants Compared to Ovaries Without Implants
International Journal of Gynecological Cancer·2006
Growth Factor Receptors in Hematopoietic Stem Cells: EPH Family Expression in CD34+ and CD133+ Cell Populations from Mobilized Peripheral Blood
International Journal of Immunopathology and Pharmacology·2006· 46 citedOpen Access
Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors?
International Journal of Gynecological Cancer·2005· 43 cited
Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method
Cytotherapy·2004· 68 cited
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence
British Journal of Cancer·2004· 161 citedOpen Access
The prognostic significance of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in breast carcinomas.
PubMed·2004· 21 cited
Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast Cancer
Journal of Clinical Oncology·2003· 284 cited
Pregnancy and breast cancer: a population-based study
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin·2003· 107 cited
Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1
Clinical & Experimental Metastasis·2003· 29 cited
page 1 of 4Next →

Frequent Co-authors

Ruth Holm(13), Claes G. Tropé(7), Elin Borgen(5), Sophie D. Fosså(5), Øystein Fodstad(5), Manuel Sobrinho‐Simões(5), Jan Vincents Johannessen(5), A L Børresen(4), Bjørn Naume(3), Rolf Kåresen(3), Eivind Hovig(3), A-L Børresen(3), Johan Moan(3), R Holm(3), A. Berner(3), M. Baekelandt(3), Gunnar B. Kristensen(3), Zhenhe Suo(3), J. Kærn(3), Berit Sandstad(3)